American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care

MEROPOL, Neal J ; SCHRAG, Deborah ; SMITH, Thomas J ; MULVEY, Therese M ; LANGDON, Robert M ; BLUM, Diane ; UBEL, Peter A ; SCHNIPPER, Lowell E

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received

Schnipper, Lowell E ; Davidson, Nancy E ; Wollins, Dana S ; Blayney, Douglas W ; Dicker, Adam P ; Ganz, Patricia A ; Hoverman, J Russell ; Langdon, Robert ; Lyman, Gary H ; Meropol, Neal J ; Mulvey, Therese ; Newcomer, Lee ; Peppercorn, Jeffrey ; Polite, Blase ; Raghavan, Derek ; Rossi, Gregory ; Saltz, Leonard ; Schrag, Deborah ; Smith, Thomas J ; Yu, Peter P ; Hudis, Clifford A ; Vose, Julie M ; Schilsky, Richard L

United States

Texto completo disponível

American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options

Schnipper, Lowell E ; Davidson, Nancy E ; Wollins, Dana S ; Tyne, Courtney ; Blayney, Douglas W ; Blum, Diane ; Dicker, Adam P ; Ganz, Patricia A ; Hoverman, J Russell ; Langdon, Robert ; Lyman, Gary H ; Meropol, Neal J ; Mulvey, Therese ; Newcomer, Lee ; Peppercorn, Jeffrey ; Polite, Blase ; Raghavan, Derek ; Rossi, Gregory ; Saltz, Leonard ; Schrag, Deborah ; Smith, Thomas J ; Yu, Peter P ; Hudis, Clifford A ; Schilsky, Richard L ; American Society of Clinical Oncology

United States: American Society of Clinical Oncology

Texto completo disponível

American Society of Clinical Oncology Clinical practice guidelines for the use of chemotherapy and radiotherapy protectants

HENSLEY, M. L ; SCHUCHTER, L. M ; NEGRIN, R ; SZATROWSKI, T. P ; THIGPEN, J. T ; VON HOFF, D ; WASSERMAN, T. H ; WINER, E. P ; PFISTER, D. G ; LINDLEY, C ; MEROPOL, N. J ; COHEN, G. I ; BRODER, G ; GRADISHAR, W. J ; GREEN, D. M ; LANGDON, R. J ; MITCHELL, R. B

Baltimore, MD: Lippincott Williams & Wilkins

Sem texto completo

Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma

Creagan, E T ; Dalton, R J ; Ahmann, D L ; Jung, S H ; Morton, R F ; Langdon, Jr, R M ; Kugler, J ; Rodrigue, L J

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Exemestane Is Superior to Megestrol Acetate After Tamoxifen Failure in Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Randomized Double-Blind Trial

KAUFMANN, M ; BAJETTA, E ; FOWST, C ; POLLI, A ; DI SALLE, E ; ARKHIPOV, A ; PISCITELLI, G ; MILLER, L. L ; MASSIMINI, G ; DIRIX, L. Y ; FEIN, L. E ; JONES, S. E ; ZILEMBO, N ; DUGARDYN, J.-L ; NASURDI, C ; MENNEL, R. G ; CERVEK, J

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Irinotecan Plus Gemcitabine Induces Both Radiographic and CA 19-9 Tumor Marker Responses in Patients With Previously Untreated Advanced Pancreatic Cancer

Rocha Lima, C. M. S.

American Society of Clinical Oncology

Sem texto completo

Irinotecan Therapy in Adults With Recurrent or Progressive Malignant Glioma

FRIEDMAN, H. S ; PETROS, W. P ; CLOUGHSEY, T ; STEWART, E. S ; COLVIN, O. M ; PROVENZALE, J. M ; MCLENDON, R. E ; BIGNER, D. D ; COKGOR, L ; HAGLUND, M ; RICH, J ; ASHLEY, D ; FRIEDMAN, A. H ; MALCZYN, J ; ELFRING, G. L ; MILLER, L. L ; SCHAAF, L. J ; KERBY, T ; LAWYER, J ; PARRY, M ; HOUGHTON, P. J ; LOVELL, S ; RASHEED, K

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

A phase I study of the toll-like receptor 5 (TLR5) agonist, entolimod in patients (pts) with advanced cancers

Bakhribah, Hatoon ; Dy, Grace K. ; Ma, Wen Wee ; Zhao, Yujie ; Opyrchal, Mateusz ; Purmal, Andrei ; Gollnick, Sandra ; Brady, William E. ; Fetterly, Gerald J. ; Ngamphaiboon, Nuttapong ; Reungwetwattana, Thanyanan ; Jacob, Sandra M ; O'Hara, Corrie ; Siedlecki, Francine ; Adjei, Araba ; Burdelya, Lyudmila ; Bespalov, Ivan ; Miller, Langdon L. ; Gudkov, Andrei ; Adjei, Alex A.

Texto completo disponível

A randomized, placebo-controlled, phase I/II study of tivantinib (ARQ 197) in combination with cetuximab and irinotecan in patients (pts) with KRAS wild-type (WT) metastatic colorectal cancer (CRC) who had received previous front-line systemic therapy

Eng, Cathy ; Hart, Lowell L. ; Severtsev, Aleksey ; Gladkov, Oleg ; Mueller, Lothar ; Kopp, Mikhail V. ; Vladimirov, Vladimir Ivanovich ; Langdon, Robert M. ; Kotiv, Bogdan ; Barni, Sandro ; Hsu, Ching ; Bolotin, Ellen ; Von Roemeling, Reinhard ; Schwartz, Brian E. ; Bendell, Johanna C.

Texto completo disponível